HS-5 Cells

The HS-5 cell line is a human bone marrow-derived mesenchymal stromal cell (MSC) model commonly used to study the supportive role of stromal cells in hematopoiesis and cancer development. Originally isolated and immortalized via the E6 and E7 human papillomavirus genes, HS-5 cells demonstrate fibroblast-like morphology and are known for secreting a wide array of cytokines and growth factors that are crucial for hematopoietic and immune cell interactions. Notable secreted factors include granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage-CSF (M-CSF), stem cell factor (SCF), interleukin-6 (IL-6), IL-8, and IL-11, among others. These secretions enable HS-5 cells to sustain the growth and proliferation of hematopoietic progenitor cells in vitro, even under serum-free conditions, highlighting their functional similarity to primary MSCs in hematopoiesis support.

In oncology research, HS-5 cells serve as a model for examining the interactions between MSCs and cancer cells, particularly in studying tumor microenvironment-mediated cancer cell survival, immune modulation, and drug resistance. Studies have shown that HS-5 cells can protect acute myeloid leukemia (AML) cells from apoptosis induced by chemotherapeutic agents like cytarabine (Ara-C) and daunomycin (DNR), potentially through mechanisms involving cytokine signaling and direct cell-cell interactions. This protective effect of HS-5 cells enhances AML cell proliferation and reduces chemotherapy efficacy, making this cell line a valuable tool for modeling drug resistance in the bone marrow microenvironment. Additionally, HS-5 cells express MSC markers such as CD73, CD90, and CD105, though their expression levels may vary compared to primary MSCs.

Furthermore, HS-5 cells have been used to explore novel therapeutic approaches, such as testing the cytotoxic effects of nanomaterials like pristine graphene. Graphene exposure in HS-5 cells has been shown to induce mitochondrial dysfunction and oxidative stress, leading to apoptosis via increased reactive oxygen species (ROS) production and disrupted mitochondrial membrane potential, thereby serving as a model for evaluating nanoparticle toxicity and therapeutic potential in stromal cell interactions within the tumor microenvironment.